RH

Richard A. Heyman

LI Ligand Pharmaceuticals Incorporated: 4 patents #8 of 65Top 15%
SS Salk Institute For Biological Studies: 2 patents #6 of 45Top 15%
BM Baylor College Of Medicine: 1 patents #4 of 40Top 10%
📍 Encinitas, CA: #5 of 149 inventorsTop 4%
🗺 California: #953 of 28,521 inventorsTop 4%
Overall (2003): #8,233 of 273,478Top 4%
5
Patents 2003

Issued Patents 2003

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors Marcus F. Boehm, Lin Zhi, Chan-Kou Hwang, Steve White, Alex M. Nadzan 2003-08-26
6576676 Means for the modulation of processes mediated by retinold receptors and compounds useful therefor Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Gregor Eichele, Christina Thaller 2003-06-10
6545049 Dimer-selective RXR modulators and methods for their use Stacie Canan-Koch, Chan-Kou Hwang, Marcus F. Boehm, Beth Ann Badea, Laura J. Dardashti +5 more 2003-04-08
6521633 Treating NIDDM with RXR agonists Rosemary Cesario, Ranjan Mukherjee 2003-02-18
6506917 Compounds and compositions useful for modulation of processes mediated by RXR Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Gregor Eichele, Christina Thaller 2003-01-14